Clinical Trial Update: DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease [Phase 2]

View source ↗

Summary

Phase 2 results update for DS-8201a (trastuzumab deruxtecan) in advanced HER2-positive breast cancer, including patients with brain metastases and leptomeningea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Leptomeningeal Metastasis

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: MedSIR | Conditions: Advanced Breast Cancer, HER2-positive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-06-24